Stryker Lawsuit Attorneys Discussing Possible UK Metal-on-Metal Hip Ban
Sources state that, following an analysis of 17,000 claims suggesting a high failure rate, a UK metal-on-metal hip ban could be put into place across that country. The proposed ban follows a review that established failure rates up to 43 percent for some metal-on-metal hip implants.
While the UK metal-on-metal hip ban does not directly affect Stryker’s similar hip implant systems, experts suggest that Stryker Orthopaedics may be faced with a similar ban in the country. If you or a loved one have been fitted with a Stryker implant and are suffering from complications, contact an attorney to learn more about filing a claim.
What is the UK Metal-on-Metal Hip Ban?
The National Institute for Health & Care Excellence (NICE) in the UK recommended that hospitals stop using implants that have demonstrated a failure rate greater than 5 percent. According to researchers, this would subsequently remove nearly all metal-on-metal hip implants from the facilities across the country.
Following the August 2010 recall of the ASR XL acetabular and ASR hip implants manufactured by DePuy Orthopaedics and the July 2012 recall of the Stryker Rejuvenate and ABG II hip implants, the UK metal-on-metal hip ban may force Stryker and Johnson & Johnson to remove devices from the UK market after agencies reported an increasing number of revision surgeries to correct or remove allegedly harmful and defective implants in patients.
Additionally, some studies have suggested that hundreds of thousands of patients may have suffered from metallosis, or a metal toxicity due to exposure from the metallic shards falling into the bloodstream. Exposure to toxic materials may place a patient at a higher risk of developing changes to DNA, bone or muscle destruction, cancer or cardiomyopathy.
Does the UK Metal-on-Metal Hip Ban Affect the U.S.?
While some question about whether the UK metal-on-metal hip implant is severe enough, others agree that it is a step in the right direction for those injured by various hip implant devices across the world. The NICE agency maintained that, in particular, the DePuy ASR implant demonstrated a 43 percent failure rate after nine years.
In 2012 alone, the FDA received 45 adverse event reports from patients suffering from injuries after receiving the Stryker ABG II or Rejuvenate implants. Over 20,000 hip implants were subsequently recalled worldwide.
Plaintiffs filing lawsuits in the U.S. following the July 2012 recall of the Stryker Rejuvenate and ABG II hip implants allege complications including:
- Muscle injury
- Dislocation whereby the metal part detaches from the hip
- Loosening whereby the metal implant separates from the bone
- Pain, inflammation
- Difficulty walking
Those filing lawsuits to seek compensation allege that the manufacturer failed to warn the medical community and public of the potentially serious and life-threatening side effects associated with the devices. Experts suggest that the manufacturer partnered with a third-party claims administrator, Broadspire Services, inc., in an effort to curb future recall lawsuits. The manufacturer, however, maintains that its intent was to help reimburse those who allegedly suffered injuries for additional procedures and costs related to the recall.
Contact an Attorney for More Information about Stryker and the UK Metal-on-Metal Hip Ban
If you received the Stryker ABG II or Rejuvenate modular-neck hip stems and suffered from complications, you may be entitled to file a claim and receive compensation for lost wages, pain, suffering and medical expenses. At the American Injury Attorney Group, we can offer you a free case evaluation to determine if you have a valid claim. We can help answer questions you may have, and we will connect you with an experienced attorney who will handle your claim and work to fight for your legal rights.